A groundbreaking therapy first introduced by Northwestern University researchers in 2021 has shown promise in regenerating ...
Objective: To evaluate the long-term effectiveness and tolerability of adalimumab in the treatment of psoriatic arthritis (PsA ... of adalimumab exposure. For patients without a week 144 modified ...